Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
Background For patients with MS, medication switches increase the risk of disease reactivation. Objective Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. Methods Al...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
SAGE Publishing
2021-06-01
|
| Sraith: | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| Rochtain ar líne: | https://doi.org/10.1177/20552173211022027 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|